Eptinezumab in episodic migraine: a randomized, double-blind, placebo-controlled study (PROMISE-1) - Ashina, M; Saper, J; Cady, R; Schaeffler, BA; Biondi, DM; Hirman, J (Cephalalgia, 2020)